Francesco Bonsante
Overview
Explore the profile of Francesco Bonsante including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allanore A, Bonsante F, Lorrain S, Lapillonne A, Iacobelli S
Respiration
. 2025 Feb;
:1-20.
PMID: 39965557
Introduction Acute respiratory disorders and bronchopulmonary dysplasia (BPD) are frequent and serious complications in very preterm infants (VPI). These conditions are influenced by several factors, including fluid imbalances and abnormal...
2.
Robillard P, Iacobelli S, Lorrain S, Bonsante F, Boukerrou M, Scioscia M, et al.
PLoS One
. 2024 Dec;
19(12):e0312507.
PMID: 39715206
Objectives: To evaluate the relative importance of changing paternity ("primipaternity", direct inquiry with patients) in multiparas versus prolonged birth/pregnancy interval as risk factors for preeclampsia (PE) by a logistic regression...
3.
Robillard P, Bonsante F, Boumahni B, Staquet P, Richard M, Guinaud J, et al.
PLoS One
. 2024 Jun;
19(6):e0301595.
PMID: 38857215
Background: Clear amniotic fluid aspiration syndrome (CAF-AS) is a very rare event occurring in 0.25% of our term clear amniotic fluids deliveries. The study's aims were: 1. to characterize the...
4.
Iacobelli S, Lorrain S, Rabe E, Gouyon B, Gouyon J, Bonsante F
Front Pharmacol
. 2024 Mar;
15:1358761.
PMID: 38545552
The use of diuretics is extremely common in infants cared for in neonatal wards, despite the lack of proven efficacy for many conditions. The main objective of this study was...
5.
Iacobelli S, Commins M, Lorrain S, Gouyon B, Ramful D, Richard M, et al.
Front Pharmacol
. 2023 Jun;
14:1200521.
PMID: 37361223
Environmental factors influence the development of very preterm infants (VPIs, born at less than 32 weeks of gestation). It is important to identify all potential sources of paraben exposure in...
6.
Robillard P, Dekker G, Scioscia M, Bonsante F, Boukerrou M, Iacobelli S, et al.
J Reprod Immunol
. 2023 Jun;
158:103968.
PMID: 37290173
The 2023 goal is to halve the incidence of preeclampsia worldwide to reach 3 million cases per year vs the current approximately 7 million cases. Preventive treatment by low dose...
7.
Iacobelli S, Allamele-Moutama K, Lorrain S, Gouyon B, Gouyon J, Bonsante F
Front Pharmacol
. 2023 Apr;
14:1170842.
PMID: 37089932
Postnatal corticosteroids (PC) are widely used in very preterm infants. International reports and national multicenter trials describe a marked variability across countries and inter-sites, in the use of PC. Few...
8.
Trigolet M, Bonsante F, Guignard J, Gouyon J, Iacobelli S
Pediatr Nephrol
. 2022 Jun;
38(3):721-727.
PMID: 35759001
Background: Preterm infants have physiological proteinuria and values of urine protein to creatinine ratio (UPr/Cr) are higher compared to full-term infants during the first week of life. Few investigations explored...
9.
Hoarau K, Payet M, Zamidio L, Bonsante F, Iacobelli S
Front Pediatr
. 2021 Feb;
8:607900.
PMID: 33520895
Oral sucrose is commonly used to provide analgesia to neonates during painful procedures, such as venepuncture. The additional benefits of reducing pain during venepuncture when oral sucrose is combined with...
10.
Iacobelli S, Lorrain S, Gouyon B, Gambacorta S, Laforgia N, Gouyon J, et al.
Eur J Clin Pharmacol
. 2020 Aug;
76(12):1765-1772.
PMID: 32740771
Purpose: To describe the exposure to drugs used for the treatment of patent ductus arteriosus (PDA) in a large cohort of preterm infants born before 32 weeks of gestation. Methods:...